ConvaTec logo

CTEC - ConvaTec News Story

237.3p -2.3  -1.0%

Last Trade - 4:35pm

Sector
Healthcare
Size
Large Cap
Market Cap £4.83bn
Enterprise Value £5.53bn
Revenue £1.36bn
Position in Universe 194th / 1813

ConvaTec Group PLC - Result of AGM

Fri 7th May, 2021 2:50pm
RNS Number : 9695X
ConvaTec Group PLC
07 May 2021
 

ConvaTec Group Plc

 

Results of Annual General Meeting

 

Reading, United Kingdom 7 May 2021 - Poll Result

 

ConvaTec Group Plc ("ConvaTec") held its annual general meeting today ("AGM"). The results of the poll held in relation to the resolutions proposed at the AGM are set out below:

 

 

For

(see note 2)

Against

(see note 2)

Total Votes cast

% of ISC Voted

Number of Votes Withheld

(see note 3)

Resolution

No of shares

%

No of shares

%

1

Receive Annual Report and Accounts

1,744,608,352

99.96

777,616

0.04

1,745,385,968

87.08%

1,480,001

2

Approve the Directors' Remuneration Report

1,698,130,077

97.23

48,413,492

2.77

1,746,543,569

87.14%

322,400

3

Declare Final Dividend

1,740,839,314

99.66

5,915,934

0.34

1,746,755,248

87.15%

110,721

4

Re-elect John McAdam as a director

1,726,805,777

98.88

19,520,971

1.12

1,746,326,748

87.13%

539,221

5

Re-elect Karim Bitar as a director

1,745,847,330

99.95

907,151

0.05

1,746,754,481

87.15%

111,488

6

Re-elect Frank Schulkes as a director

1,739,573,569

99.59

7,176,168

0.41

1,746,749,737

87.15%

116,232

7

Re-elect Margaret Ewing as a director

1,735,171,507

99.34

11,573,127

0.66

1,746,744,634

87.15%

121,335

8

Re-elect Brian May as a director

1,726,852,048

98.86

19,898,392

1.14

1,746,750,440

87.15%

115,529

9

Re-elect Rick Anderson as a director

1,732,922,453

99.21

13,822,181

0.79

1,746,744,634

87.15%

121,335

10

Re-elect Regina Benjamin as a director

1,733,824,898

99.26

12,925,036

0.74

1,746,749,934

87.15%

116,035

11

Re-elect Sten Scheibye as a director

1,745,567,146

99.93

1,187,335

0.07

1,746,754,481

87.15%

111,488

12

Elect Heather Mason as a director

1,744,886,278

99.89

1,863,459

0.11

1,746,749,737

87.15%

116,232

13

Elect Constantin Coussios as a director

1,744,393,943

99.87

2,356,497

0.13

1,746,750,440

87.15%

115,529

14

Re-appoint Deloitte LLP as auditor

1,746,633,262

99.99

118,345

0.01

1,746,751,607

87.15%

114,362

15

Authorise the directors to determine the remuneration of the Company's auditor

1,746,753,488

100.00

433

0.00

1,746,753,921

87.15%

112,048

16

Authorise political donations and political expenditure

1,721,717,493

98.58

24,812,022

1.42

1,746,529,515

87.14%

336,454

17

Authorise allotment of shares

1,623,589,106

92.97

122,709,426

7.03

1,746,298,532

87.13%

567,437

18

Disapply pre-emption rights*

1,736,680,253

99.45

9,522,182

0.55

1,746,202,435

87.12%

663,534

19

Disapply pre-emption rights in connection with an acquisition or specified capital investment*

1,691,979,685

96.87

54,580,936

3.13

1,746,560,621

87.14%

305,348

20

Authorise purchase of own shares*

1,741,411,621

99.75

4,350,959

0.25

1,745,762,580

87.10%

1,103,389

21

Call general meetings on 14 days' notice*

1,657,330,730

94.88

89,418,003

5.12

1,746,748,733

87.15%

117,236

 

*Special Resolution

 

 

NOTES:

1.   All resolutions were passed.

2.   Votes "For" and "Against" are expressed as a percentage of votes received.

3.   A "Vote withheld" is not a vote in law and is not counted in the calculation of the votes "For" or "Against" a resolution.

4.   Total number of shares in issue at close of business on 5 May 2021 was 2,004,347,138 shares; 87.15% of voting capital was instructed.

5.   Computershare acted as scrutineer of the poll on all resolutions.

 

In accordance with Listing Rule 9.6.2, copies of the resolutions that do not constitute ordinary business that were passed at the Meeting will be submitted to the National Storage Mechanism and will be available for inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

 

 

About ConvaTec

 

ConvaTec is a global medical products and technologies company focused on therapies for the management of chronic conditions, with leading market positions in advanced wound care, ostomy care, continence and critical care, and infusion care. Our vision, which encompasses our purpose, is: Pioneering trusted medical solutions to improve the lives we touch. Our products provide a range of clinical and economic benefits including infection prevention, protection of at-risk skin, improved patient outcomes and reduced total cost of care. To learn more about ConvaTec, please visit www.convatecgroup.com

 

 

Enquiries

 

 

Analysts and Investors

Kate Postans, Vice President Investor Relations, ConvaTec    +44 (0)7826 447 807

ir@convatec.com

 

Media

Buchanan: Charles Ryland / Chris Lane                                    +44 (0)207 466 5000                                                                                                        

 

ConvaTec Group Plc's LEI code is 213800LS272L4FIDOH92

 

 

 

 

 

                                                                       # # #

                                                                       END

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGUBSORAOUVRAR
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.